rindopepimut/GM-CSF

rindopepimut · Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rindopepimut/GM-CSF, covering 2018-01-16 to 2020-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma [Phase 2]